VIOL Valuation

Is A335890 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of A335890 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: A335890 (₩8530) is trading above our estimate of fair value (₩567.77)

Significantly Below Fair Value: A335890 is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for A335890?

Other financial metrics that can be useful for relative valuation.

A335890 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenuen/a
Enterprise Value/EBITDAn/a
PEG Ration/a

Price to Book Ratio vs Peers

How does A335890's PB Ratio compare to its peers?

The above table shows the PB ratio for A335890 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PBEstimated GrowthMarket Cap
Peer Average5x
A336570 WON TECHLtd
4.3x37.9%₩464.6b
A099190 i-SENS
1.8x62.9%₩544.1b
A145720 Dentium
1x14.1%₩501.0b
A314930 Biodyne
13x63.4%₩617.6b
n/a28.0%₩473.5b

Price-To-Book vs Peers: Insufficient data to calculate A335890's Price-To-Book Ratio vs. peers for valuation analysis.


Price to Earnings Ratio vs Industry

How does A335890's PE Ratio compare vs other companies in the KR Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a35.0%
n/an/an/a
No. of CompaniesPB048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a35.0%
n/an/an/a
No more companies

Price-To-Book vs Industry: Insufficient data to calculate A335890's Price-To-Book Ratio vs. industry for valuation analysis.


Price to Book Ratio vs Fair Ratio

What is A335890's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

A335890 PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ration/a
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate A335890's Price-To-Book Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst A335890 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₩8,530.00
₩13,666.67
+60.2%
8.1%₩16,000.00₩13,000.00n/a6
Nov ’25₩8,130.00
₩13,666.67
+68.1%
8.1%₩16,000.00₩13,000.00n/a6
Oct ’25₩8,900.00
₩13,666.67
+53.6%
8.1%₩16,000.00₩13,000.00n/a6
Sep ’25₩8,280.00
₩13,666.67
+65.1%
8.1%₩16,000.00₩13,000.00n/a6
Aug ’25₩10,190.00
₩13,666.67
+34.1%
8.1%₩16,000.00₩13,000.00n/a6
Jul ’25₩10,640.00
₩13,533.33
+27.2%
6.1%₩15,200.00₩13,000.00n/a6
Jun ’25₩10,670.00
₩13,640.00
+27.8%
6.4%₩15,200.00₩13,000.00n/a5
May ’25₩10,080.00
₩11,500.00
+14.1%
9.7%₩13,000.00₩10,000.00n/a4
Apr ’25₩11,730.00
₩10,875.00
-7.3%
12.3%₩13,000.00₩9,500.00n/a4
Mar ’25₩7,320.00
₩10,875.00
+48.6%
12.3%₩13,000.00₩9,500.00n/a4
Feb ’25₩7,420.00
₩10,875.00
+46.6%
12.3%₩13,000.00₩9,500.00n/a4
Jan ’25₩8,500.00
₩10,600.00
+24.7%
10.4%₩11,700.00₩9,500.00n/a2

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies